|1||NCT03007147||Recruiting||Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia||
||Other / NIH||
||700||All||2 Years to 21 Years (Child, Adult)||NCT03007147||AALL1631
|July 28, 2017||June 1, 2026||June 2026||January 2, 2017||May 4, 2018||
|2||NCT02003222||Recruiting||Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia||
||360||All||30 Years to 70 Years (Adult, Older Adult)||NCT02003222||NCI-2013-02229
|December 23, 2013||June 30, 2021||December 6, 2013||June 4, 2018||
† Study has passed its completion date and status has not been verified in more than two years.